Banka BioLoo Limited
Banka BioLoo Limited (BANKA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
bankabio.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11 Cr | 14 Cr | 16 Cr | 13 Cr | 12 Cr | 14 Cr | 15 Cr | 11 Cr | 13 Cr | 15 Cr | 18 Cr | 11 Cr |
| Operating expenses (approx.) | 9 Cr | 12 Cr | 15 Cr | 11 Cr | 17 Cr | 14 Cr | 15 Cr | 11 Cr | 13 Cr | 14 Cr | 14 Cr | 9 Cr |
| EBITDA | 2 Cr | 2 Cr | 1 Cr | 2 Cr | -4 Cr | 0.03 Cr | -0.17 Cr | 0.34 Cr | -0.0094 Cr | 1 Cr | 3 Cr | 2 Cr |
| OPM % | 20.0% | 12.7% | 6.6% | 13.6% | -36.1% | 0.2% | -1.1% | 3.1% | -0.1% | 9.6% | 19.1% | 17.2% |
| Other income | 0.09 Cr | 0.11 Cr | 0.12 Cr | 0.11 Cr | 0.08 Cr | 0.11 Cr | 0.02 Cr | 1 Cr | 0.05 Cr | 0.05 Cr | 0.14 Cr | 0.10 Cr |
| Interest | 0.68 Cr | 0.65 Cr | 0.63 Cr | 0.87 Cr | 0.85 Cr | 1 Cr | 1 Cr | 0.89 Cr | 0.93 Cr | 0.91 Cr | 0.93 Cr | 1 Cr |
| Depreciation | 0.55 Cr | 0.56 Cr | 0.61 Cr | 0.62 Cr | 0.62 Cr | 0.63 Cr | 0.66 Cr | 0.64 Cr | 0.70 Cr | 0.77 Cr | 0.69 Cr | 0.85 Cr |
| Profit before tax | 1 Cr | 0.67 Cr | -0.09 Cr | 0.38 Cr | -6 Cr | -1 Cr | -2 Cr | -0.13 Cr | -2 Cr | -0.15 Cr | 2 Cr | -0.09 Cr |
| Tax % | -5.1% | -2.5% | -162.8% | 22.2% | 0.8% | 2.2% | 11.9% | 101.7% | 30.6% | 15.8% | -1.7% | 54.2% |
| Net profit | 1 Cr | 0.69 Cr | -0.25 Cr | 0.29 Cr | -6 Cr | -1 Cr | -2 Cr | 0.0021 Cr | -1 Cr | -0.12 Cr | 2 Cr | -0.04 Cr |
| EPS (₹) | ₹1.12 | ₹0.65 | ₹0.22 | ₹0.27 | ₹-5.65 | ₹-1.34 | ₹-1.50 | ₹0.00 | ₹-1.00 | ₹-0.14 | ₹1.45 | ₹-0.01 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 30 Cr | 39 Cr | 42 Cr | 50 Cr | 54 Cr | 57 Cr | Sign in for TTM |
| Operating expenses (approx.) | 27 Cr | 33 Cr | 36 Cr | 46 Cr | 57 Cr | 52 Cr | Sign in for TTM |
| EBITDA | 3 Cr | 6 Cr | 6 Cr | 4 Cr | -3 Cr | 5 Cr | Sign in for TTM |
| OPM % | 11.2% | 14.2% | 14.0% | 7.3% | -5.3% | 9.1% | Sign in for TTM |
| Other income | 0.58 Cr | 0.45 Cr | 0.70 Cr | 0.49 Cr | 0.33 Cr | 1 Cr | Sign in for TTM |
| Interest | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 4 Cr | 4 Cr | Sign in for TTM |
| Depreciation | 0.60 Cr | 0.94 Cr | 1 Cr | 2 Cr | 3 Cr | 3 Cr | Sign in for TTM |
| Profit before tax | 2 Cr | 3 Cr | 4 Cr | -0.56 Cr | -9 Cr | -0.26 Cr | Sign in for TTM |
| Tax % | -18.0% | 6.1% | 29.9% | -19.1% | 2.4% | 248.5% | Sign in for TTM |
| Net profit | 2 Cr | 3 Cr | 3 Cr | -0.67 Cr | -9 Cr | 0.39 Cr | Sign in for TTM |
| EPS (₹) | ₹2.15 | ₹3.02 | ₹2.39 | ₹0.60 | ₹-8.21 | ₹0.32 | Sign in for TTM |
| Dividend payout % | — | 0.0% | 0.0% | — | — | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 10 Cr | 11 Cr | 11 Cr | 11 Cr | 11 Cr | 11 Cr |
| Reserves | 0 Cr | 27 Cr | 29 Cr | 29 Cr | 21 Cr | 29 Cr |
| Borrowings | — | — | 15 Cr | 25 Cr | 34 Cr | 39 Cr |
| Other liabilities | — | — | 10 Cr | 13 Cr | 16 Cr | 19 Cr |
| Total liabilities | — | — | 65 Cr | 77 Cr | 82 Cr | 101 Cr |
| Fixed assets (net) | — | — | 9 Cr | 14 Cr | 15 Cr | 26 Cr |
| CWIP | — | — | 3 Cr | 7 Cr | 8 Cr | 0.48 Cr |
| Investments | — | — | 0.06 Cr | 0.02 Cr | 0.04 Cr | 0.07 Cr |
| Loans & advances | — | — | 0.22 Cr | 0.13 Cr | 0 Cr | 0 Cr |
| Inventories | — | — | 9 Cr | 8 Cr | 6 Cr | 6 Cr |
| Trade receivables | — | — | 12 Cr | 23 Cr | 28 Cr | 29 Cr |
| Cash & bank | — | — | 0.84 Cr | 0.31 Cr | 0.25 Cr | 10 Cr |
| Other assets | — | — | 31 Cr | 25 Cr | 25 Cr | 28 Cr |
| Total assets | — | — | 65 Cr | 77 Cr | 82 Cr | 101 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | — | -0.44 Cr | 10 Cr | 3 Cr | 0.87 Cr | 1 Cr |
| Cash from investing | — | -3 Cr | -6 Cr | -9 Cr | -6 Cr | -2 Cr |
| Cash from financing | — | 0.95 Cr | -3 Cr | 7 Cr | 5 Cr | 11 Cr |
| Net cash flow | — | -2 Cr | 0.52 Cr | 0.13 Cr | -0.07 Cr | 10 Cr |
| Free cash flow (OCF − Capex) | — | -4 Cr | 3 Cr | -7 Cr | -4 Cr | -5 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | — | 13.5% | 9.4% | 3.0% | -8.1% | 4.2% |
| ROE % | — | 0.0% | 0.0% | -1.2% | -28.2% | 0.8% |
| Debtor days | — | — | 101 | 168 | 187 | 186 |
| Inventory days | — | — | 535 | 280 | 136 | 162 |
| Days payable | — | — | 193 | 133 | 128 | 211 |
| Cash conversion cycle | — | — | 443 | 315 | 195 | 136 |
| Debt / equity | 0.00 | — | 0.37 | 0.62 | 1.09 | 0.99 |
| Current ratio | — | — | 2.24 | 1.95 | 1.41 | 1.58 |
| Net debt / EBITDA | 0.00 | 0.00 | 2.39 | 6.75 | — | 5.61 |